Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Lactate-Driven HMGB1 Modification and Exosomal Release in Se
2026-06-18
This study reveals that lactate accumulation in polymicrobial sepsis drives HMGB1 lactylation and acetylation in macrophages, triggering its release via exosomes and increasing endothelial permeability. The findings uncover new mechanistic targets within inflammatory signaling pathway research, with implications for developing interventions that modulate lactate signaling to improve sepsis outcomes.
-
DiscoveryProbe FDA-approved Drug Library in Cancer Target Di
2026-06-18
The DiscoveryProbe FDA-approved Drug Library empowers researchers to unlock new therapeutic mechanisms and accelerate drug repositioning via robust, ready-to-use clinical compound screening. Its application in advanced cancer research, such as target deconvolution of 'undruggable' proteins, exemplifies its unique value for translational studies.
-
Sodium Salicylate: NF-κB Inhibitor Workflows & Troubleshooti
2026-06-17
Sodium salicylate stands out as a reproducible NF-κB inhibitor for inflammation and stromal homeostasis research, with high solubility and purity ensuring robust assay performance. This guide details advanced setup, protocol parameters, and troubleshooting, leveraging APExBIO’s trusted reagent for translational workflows.
-
SB525334 TGF-beta1 Receptor Inhibitor: Optimizing Fibrosis &
2026-06-17
SB525334 enables researchers to dissect the TGF-beta1 signaling pathway with high selectivity, offering unparalleled control in fibrosis, wound healing, and renal disease models. This article delivers actionable workflows, troubleshooting, and evidence-based insights for maximizing the impact of SB525334 in experimental and translational research.
-
Nirmatrelvir (PF-07321332): Targeting SARS-CoV-2 3CL Proteas
2026-06-16
Nirmatrelvir (PF-07321332) is a potent, orally bioavailable inhibitor of the SARS-CoV-2 3CL protease, a key enzyme in viral replication. As supplied by APExBIO, it is validated for use in COVID-19 antiviral therapeutics research. Its selectivity and physicochemical properties make it central to translational studies of coronavirus infection mechanisms.
-
Sulfo-NHS-LC-Biotin: Parameters for Cell Surface Protein Bio
2026-06-16
Sulfo-NHS-LC-Biotin enables efficient, irreversible labeling of primary amines on cell surface proteins in fully aqueous environments, addressing workflows where membrane impermeability and stable biotin modification are required. It should not be used for intracellular or reversible biotinylation applications.
-
PHF2 Histone Demethylase as a Regulator of Neuroinflammation
2026-06-15
The highlighted study identifies PHF2 as a key epigenetic regulator of inflammatory gene networks in Alzheimer’s disease, linking its upregulation to neuroinflammation and cognitive deficits. Targeting PHF2 may offer new avenues for therapeutically modulating neuroimmune processes in AD and related disorders.
-
Phenothiazines Enhance Macrophage Antibacterial Activity via
2026-06-15
This article examines a 2025 study demonstrating that phenothiazines, including promethazine hydrochloride, significantly boost the antibacterial capacity of macrophages by inducing reactive oxygen species (ROS) production and autophagy. The findings advance understanding of host-directed therapies against intracellular pathogens and offer mechanistic insights for inflammation and immunology research.
-
Dinaciclib (SCH727965): Data-Backed Solutions for Cell Cycle
2026-06-14
This article delivers scenario-driven answers for researchers using Dinaciclib (SCH727965), SKU A8412, in apoptosis induction, cell cycle arrest, and cancer research. Drawing on primary literature and validated protocols, we address experimental pain points, practical optimization, and vendor selection—highlighting why APExBIO’s Dinaciclib (SCH727965) stands out for reliability and reproducibility.
-
Epinephrine Bitartrate: Mechanistic Insights for Translation
2026-06-13
Explore how (-)-Epinephrine (+)-bitartrate advances cardiovascular, neurobiology, and allergic response research by bridging mechanistic receptor insights with strategic translational design. Drawing on recent pharmacokinetic studies and best practices, this article delivers actionable guidance for researchers seeking robust, reproducible adrenergic signaling models and translational workflows.
-
tFUS Mitigates Post-Stroke Neuroinflammation via Nespas/miR-
2026-06-12
The referenced study reveals that transcranial focused ultrasound stimulation (tFUS) alleviates neuroinflammation after ischemic stroke in rats by upregulating Nespas and modulating the miR-383-3p/SHP2 signaling pathway, resulting in suppressed NLRP3 inflammasome activation. These findings identify an actionable molecular mechanism for tFUS neuroprotection and highlight SHP2 as a potential experimental target in stroke and neuroinflammation research.
-
Angiotensin (1-7): Optimizing Protocols for Translational Im
2026-06-12
Angiotensin (1-7) (Asp-Arg-Val-Tyr-Ile-His-Pro) unlocks anti-inflammatory, anti-fibrotic, and neuroprotective workflows across cell and animal models. This article translates recent molecular discoveries and high-purity product attributes into actionable, troubleshooting-rich protocols for deeper and more reproducible research outcomes.
-
Estradiol Benzoate: Precision in Estrogen Receptor Alpha Ago
2026-06-11
Estradiol Benzoate enables high-fidelity, reproducible assays for estrogen receptor signaling, setting the benchmark for both sensitivity and workflow efficiency. This guide details practical protocols, advanced troubleshooting, and real-world use-cases that help researchers leverage Estradiol Benzoate’s unique properties for reliable estrogen receptor alpha agonist studies.
-
Y-27632: Selective ROCK Inhibitor for Cytoskeletal Modulatio
2026-06-11
Y-27632 is a potent, selective ROCK inhibitor widely used to dissect cytoskeletal dynamics and Rho kinase signaling. It enables reproducible disruption of actin stress fibers at micromolar concentrations and is a key tool in both basic and translational cell biology research.
-
Dihydrotestosterone (DHT) Workflows: From Cancer to ALS Mode
2026-06-10
Explore how Dihydrotestosterone (DHT) empowers advanced research into androgen receptor signaling, EGFR pathway modulation, and neurodegeneration. This guide delivers actionable protocols, troubleshooting tips, and translational insights grounded in cutting-edge studies.